has been cited by the following article(s):
[1]
|
Immunomagnetic Reduction Detects Plasma Aβ 1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline
|
|
2020 |
|
|
[2]
|
Associations Between Plasma Biomarkers and Cognition in Patients with Alzheimer's Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and …
|
|
2019 |
|
|
[3]
|
Analysis of apolipoprotein E genetic variation in patients with Alzheimer disease referred to Imam Reza Clinic, Rasht, Iran, in 2015
|
|
2017 |
|
|
[4]
|
Numerical Simulations Reveal Randomness of Cu (II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses
|
|
PLOS ONE,
2017 |
|
|
[5]
|
in vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings
|
|
Ageing Research Reviews,
2017 |
|
|
[6]
|
A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease
|
|
SAGE Open Medicine,
2015 |
|
|
[7]
|
Association of Apolipoprotein E Genetic Variation in Alzheimer's Disease in Indian Population A Meta-Analysis
|
|
American journal of Alzheimer's disease and other dementias,
2014 |
|
|
[8]
|
Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis
|
|
American Journal of Alzheimer's Disease & Other Dementias?,
2014 |
|
|
[1]
|
Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer’s Disease (Type 3 Diabetes)
Journal of Alzheimer's Disease,
2023
DOI:10.3233/JAD-230555
|
|
|
[2]
|
Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline
Neurology and Therapy,
2020
DOI:10.1007/s40120-020-00215-2
|
|
|
[3]
|
Associations between Plasma Biomarkers and Cognition in Patients with Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: A Cross-Sectional and Longitudinal Study
Journal of Clinical Medicine,
2019
DOI:10.3390/jcm8111893
|
|
|
[4]
|
Numerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses
PLOS ONE,
2017
DOI:10.1371/journal.pone.0170749
|
|
|
[5]
|
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings
Ageing Research Reviews,
2017
DOI:10.1016/j.arr.2017.03.002
|
|
|
[6]
|
A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease
SAGE Open Medicine,
2015
DOI:10.1177/2050312115598250
|
|
|
[7]
|
Association of Apolipoprotein E Genetic Variation in Alzheimer’s Disease in Indian Population
American Journal of Alzheimer's Disease & Other Dementiasr,
2014
DOI:10.1177/1533317514531443
|
|
|